Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.
Institute of Biomedical Informatics, National Yang Ming Chiao Tung University, Taipei, Taiwan.
United European Gastroenterol J. 2024 Feb;12(1):139-151. doi: 10.1002/ueg2.12507. Epub 2023 Dec 12.
Gastric cancer is the fifth most common cancer globally, with about 75% of cases occurring in Asia. While chronic atrophic gastritis (CAG) and intestinal metaplasia (IM) are well-recognized preneoplastic gastric lesions, we determined the prevalence and temporal trend of CAG and IM in Asia over the past 50 years.
In this systematic review and meta-analysis, we searched PubMed, Embase, MEDLINE, Scopus, and Web of Science for studies reporting the prevalence of CAG and IM in Asia (according to the United Nations geoscheme) published between 1970 and 2022. Heterogeneity was assessed by the I index and Cochran Q test. We adopted the random effects model to estimate the pooled prevalence and 95% confidence interval (CI). The slope of prevalence was estimated as a function of time in simple linear regression and weighted meta-regression models to demonstrate the temporal trend. Studies that reported the odds ratio (OR) of Helicobacter pylori infection and CAG/IM were analyzed separately to compile a pooled OR with a 95% CI. This study was registered in INPLASY2022120028.
Of the 81 studies from 19 Asian countries identified, the pooled prevalence for CAG and IM in Asia was 26.1% (95%CI: 22.7-30.0) and 22.9% (95%CI: 19.7-26.6), respectively. Over the past 5 decades, there was a significant decline in the prevalence of IM (slope in adjusted meta-regression models: -0.79 [95%CI: -1.28 to -0.26], P = 0.003), but there was no significant change in the pooled prevalence of CAG. Within Asia, the prevalence varied significantly among different regions. Southern Asia reported the highest pooled prevalence of CAG (42.9%, 95%CI: 27.5%-67.1%), while Western Asia reported the lowest level (12.7%, 95%CI: 5.0%-32.3%). For IM, Eastern Asia reported the highest prevalence (27.1%, 95%CI: 21.1-34.9), with the lowest prevalence reported in Western Asia (3.1%; 95% CI 1.2%-8.0%). H. pylori infection was linked to CAG and IM with OR of 2.16 (95%CI: 2.09-2.22) and 1.64 (95%CI: 1.57-1.72), respectively.
This updated meta-analysis showed that up to 26% of study individuals in Asia harbored preneoplastic gastric lesions. There was a declining temporal trend in the prevalence of IM, but not for CAG, in Asia.
胃癌是全球第五大常见癌症,约 75%的病例发生在亚洲。虽然慢性萎缩性胃炎(CAG)和肠上皮化生(IM)是公认的癌前胃病变,但我们确定了过去 50 年来亚洲 CAG 和 IM 的流行率和时间趋势。
在这项系统评价和荟萃分析中,我们检索了 PubMed、Embase、MEDLINE、Scopus 和 Web of Science,以查找自 1970 年至 2022 年期间发表的关于亚洲(根据联合国地理方案)CAG 和 IM 流行率的研究报告。使用 I 指数和 Cochran Q 检验评估异质性。我们采用随机效应模型估计汇总的流行率和 95%置信区间(CI)。通过简单线性回归和加权荟萃回归模型来估计患病率的斜率,以显示时间趋势。分别分析报告幽门螺杆菌感染和 CAG/IM 的比值比(OR)的研究,以编译具有 95%CI 的汇总 OR。本研究已在 INPLASY2022120028 注册。
在来自 19 个亚洲国家的 81 项研究中,亚洲的 CAG 和 IM 总体流行率分别为 26.1%(95%CI:22.7-30.0)和 22.9%(95%CI:19.7-26.6)。在过去的 50 年里,IM 的流行率呈显著下降趋势(调整后的荟萃回归模型斜率:-0.79 [95%CI:-1.28 至-0.26],P=0.003),但 CAG 的总体流行率没有明显变化。在亚洲内部,不同地区的流行率差异显著。南亚报告的 CAG 总体流行率最高(42.9%,95%CI:27.5%-67.1%),而西亚报告的流行率最低(12.7%,95%CI:5.0%-32.3%)。对于 IM,东亚报告的流行率最高(27.1%,95%CI:21.1-34.9),而西亚报告的流行率最低(3.1%;95%CI 1.2%-8.0%)。幽门螺杆菌感染与 CAG 和 IM 相关,OR 分别为 2.16(95%CI:2.09-2.22)和 1.64(95%CI:1.57-1.72)。
这项更新的荟萃分析显示,亚洲多达 26%的研究个体存在癌前胃病变。亚洲 CAG 和 IM 的流行率呈下降趋势,但 CAG 没有变化。